Literature DB >> 28781675

Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer.

Hei Cheul Jeung1, Sun Young Rha2, Sang Joon Shin2, Joong Bae Ahn2, Kyu Hyun Park2, Tae Soo Kim2, Jin Ju Kim3, Jae Kyung Roh2, Hyun Cheol Chung2.   

Abstract

Human telomerase reverse transcriptase (hTERT) expression level may not always correlate with telomerase activity. The present study analyzed hTERT splicing patterns with respect to hTERT and telomerase activity in colorectal cancer. Telomerase activity was determined by telomeric repeat amplification protocol assay, and spliced variants of hTERT were identified by reverse transcription-polymerase chain reaction in 40 colorectal cancer tissue samples. In the lower range of telomerase activity (0-100 units), the percentage of the β variant decreased with the increment in telomerase activity, whereas in the higher range of telomerase activity (>100 units), total hTERT expression level revealed a trend toward increment. There was a positive correlation between the full-length variant level and β variant level. Conversely, there was a negative correlation between the percentage of the full-length variant and β variant. Tumor-node-metastasis stage was the strongest prognostic factor in multivariate analysis and the percentage of the full-length variant was an independent prognostic factor for survival. Telomerase activity was primarily altered with changes in alternative splicing of the full-length and β variants of hTERT in colorectal cancer.

Entities:  

Keywords:  alternative splicing; colorectal cancer; full-length; telomerase activity; β variant

Year:  2017        PMID: 28781675      PMCID: PMC5530180          DOI: 10.3892/ol.2017.6438

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  31 in total

1.  Human normal T lymphocytes and lymphoid cell lines do express alternative splicing variants of human telomerase reverse transcriptase (hTERT) mRNA.

Authors:  Marit Jalink; Zheng Ge; Cheng Liu; Magnus Björkholm; Astrid Gruber; Dawei Xu
Journal:  Biochem Biophys Res Commun       Date:  2006-12-27       Impact factor: 3.575

2.  Alteration of hTERT full-length variant expression level showed different gene expression profiles and genomic copy number changes in breast cancer.

Authors:  Sun Y Rha; Hei C Jeung; Woo I Yang; Jin J Kim; Tae J Oh; Sung W An; Hyun C Chung
Journal:  Oncol Rep       Date:  2006-04       Impact factor: 3.906

3.  Differential hTERT mRNA processing between young and older glioma patients.

Authors:  A Shervington; R Patel
Journal:  FEBS Lett       Date:  2008-04-22       Impact factor: 4.124

4.  Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells.

Authors:  X Yi; J W Shay; W E Wright
Journal:  Nucleic Acids Res       Date:  2001-12-01       Impact factor: 16.971

5.  Regulation of telomerase activity by alternate splicing of human telomerase reverse transcriptase mRNA in a subset of neuroblastomas.

Authors:  M Krams; A Claviez; K Heidorn; G Krupp; R Parwaresch; D Harms; P Rudolph
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

6.  Combination of telomerase antisense oligonucleotides simultaneously targeting hTR and hTERT produces synergism of inhibition of telomerase activity and growth in human colon cancer cell line.

Authors:  Xiao-Hua Fu; Jian-Song Zhang; Na Zhang; Yang-De Zhang
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

7.  Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT.

Authors:  S L Weinrich; R Pruzan; L Ma; M Ouellette; V M Tesmer; S E Holt; A G Bodnar; S Lichtsteiner; N W Kim; J B Trager; R D Taylor; R Carlos; W H Andrews; W E Wright; J W Shay; C B Harley; G B Morin
Journal:  Nat Genet       Date:  1997-12       Impact factor: 38.330

8.  Increase of telomerase activity and hTERT expression in myelodysplastic syndromes.

Authors:  Federica Briatore; Giuseppina Barrera; Stefania Pizzimenti; Cristina Toaldo; Chiara Della Casa; Stefano Laurora; Piergiorgio Pettazzoni; Mario Umberto Dianzani; Dario Ferrero
Journal:  Cancer Biol Ther       Date:  2009-05-08       Impact factor: 4.742

9.  The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3.

Authors:  Cheng Liu; Xiaolei Fang; Zheng Ge; Marit Jalink; Satoru Kyo; Magnus Björkholm; Astrid Gruber; Jan Sjöberg; Dawei Xu
Journal:  Cancer Res       Date:  2007-03-15       Impact factor: 12.701

10.  Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells.

Authors:  Mikako Moriai; Naoki Tsuji; Daisuke Kobayashi; Kageaki Kuribayashi; Naoki Watanabe
Journal:  Int J Oncol       Date:  2009-05       Impact factor: 5.650

View more
  2 in total

1.  Alternative splicing of human telomerase reverse transcriptase in gliomas and its modulation mediated by CX-5461.

Authors:  Guihong Li; Jing Shen; Junguo Cao; Guangtong Zhou; Ting Lei; Yuxue Sun; Haijun Gao; Yaonan Ding; Weidong Xu; Zhixin Zhan; Yong Chen; Haiyan Huang
Journal:  J Exp Clin Cancer Res       Date:  2018-04-10

Review 2.  Alternative Splicing of Human Telomerase Reverse Transcriptase (hTERT) and Its Implications in Physiological and Pathological Processes.

Authors:  Anna A Plyasova; Dmitry D Zhdanov
Journal:  Biomedicines       Date:  2021-05-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.